These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15749920)

  • 81. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
    Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA
    J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
    Mannie MD; Morrison-Plummer J; McConnell TJ
    J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differentiated Th1 autoreactive effector cells can induce experimental autoimmune encephalomyelitis in the absence of IL-12 and CD40/CD40L interactions.
    Mendel I; Shevach EM
    J Neuroimmunol; 2002 Jan; 122(1-2):65-73. PubMed ID: 11777544
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
    Dalal M; Kim S; Voskuhl RR
    J Immunol; 1997 Jul; 159(1):3-6. PubMed ID: 9200430
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE.
    Menezes JS; van den Elzen P; Thornes J; Huffman D; Droin NM; Maverakis E; Sercarz EE
    J Clin Invest; 2007 Aug; 117(8):2176-85. PubMed ID: 17627303
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.
    Khoury SJ; Hancock WW; Weiner HL
    J Exp Med; 1992 Nov; 176(5):1355-64. PubMed ID: 1383385
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes.
    Karussis D; Abramsky O; Rosenthal Y; Mizrachi-Koll R; Ovadia H
    Immunol Lett; 1999 Apr; 67(3):203-8. PubMed ID: 10369127
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice.
    Chen Y; Hancock WW; Marks R; Gonnella P; Weiner HL
    J Neuroimmunol; 1998 Mar; 82(2):149-59. PubMed ID: 9585811
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A fusion protein consisting of IL-16 and the encephalitogenic peptide of myelin basic protein constitutes an antigen-specific tolerogenic vaccine that inhibits experimental autoimmune encephalomyelitis.
    Mannie MD; Abbott DJ
    J Immunol; 2007 Aug; 179(3):1458-65. PubMed ID: 17641011
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A gene therapy approach for treating T-cell-mediated autoimmune diseases.
    Chen C; Rivera A; Ron N; Dougherty JP; Ron Y
    Blood; 2001 Feb; 97(4):886-94. PubMed ID: 11159513
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis.
    Song F; Guan Z; Gienapp IE; Shawler T; Benson J; Whitacre CC
    J Immunol; 2006 Aug; 177(3):1500-9. PubMed ID: 16849456
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity.
    Waisman A; Ruiz PJ; Hirschberg DL; Gelman A; Oksenberg JR; Brocke S; Mor F; Cohen IR; Steinman L
    Nat Med; 1996 Aug; 2(8):899-905. PubMed ID: 8705860
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis.
    Faunce DE; Terajewicz A; Stein-Streilein J
    J Immunol; 2004 Feb; 172(4):1991-5. PubMed ID: 14764660
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigen-specific Th2 cells.
    Schif-Zuck S; Westermann J; Netzer N; Zohar Y; Meiron M; Wildbaum G; Karin N
    J Immunol; 2005 Apr; 174(7):4307-15. PubMed ID: 15778395
    [TBL] [Abstract][Full Text] [Related]  

  • 98. IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen.
    Ochoa-Repáraz J; Rynda A; Ascón MA; Yang X; Kochetkova I; Riccardi C; Callis G; Trunkle T; Pascual DW
    J Immunol; 2008 Jul; 181(2):954-68. PubMed ID: 18606647
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The critical role of IL-12 and the IL-12R beta 2 subunit in the generation of pathogenic autoreactive Th1 cells.
    Shevach EM; Chang JT; Segal BM
    Springer Semin Immunopathol; 1999; 21(3):249-62. PubMed ID: 10666772
    [TBL] [Abstract][Full Text] [Related]  

  • 100. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.
    Löhning M; Stroehmann A; Coyle AJ; Grogan JL; Lin S; Gutierrez-Ramos JC; Levinson D; Radbruch A; Kamradt T
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6930-5. PubMed ID: 9618516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.